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Background: The positive association between caesarean section (CS) and autism spectrum 
disorder (ASD) may be attributed to preterm delivery. However, due to lack of statistical power, no 
previous study thoroughly examined this association across gestational age. Moreover, most studies 
did not differentiate between emergency and planned CS.  
Methods: Using population-based registries of four Nordic countries and Western Australia, our 
study population included 4987390 singletons surviving their first year of life, which included 
671646 CS deliveries and 31073 ASD children. We used logistic regression to estimate odds ratios 
(OR) and their 95% confidence intervals (CI) for CS, adjusted for gestational age, site, maternal age 
and birth year. Stratified analyses were conducted by both gestational age subgroups and by week 
of gestation. We compared emergency versus planned CS to investigate their potential difference on 
the risk of ASD.  
Results: Compared with vaginal delivery, the overall adjusted OR for ASD in CS delivery was 1.26 
(95% CI 1.22-1.30). Stratified ORs were 1.25 (1.15-1.37), 1.16 (1.09-1.23), 1.34 (1.28-1.40) and 
1.17 (1.04-1.30) for subgroups of gestational week 26-36, 37-38, 39-41 and 42-44, respectively. CS 
was significantly associated with risk of ASD for each week of gestation, from week 36 to 42, 
consistently across study sites (OR ranged 1.16-1.38). There was no statistically significant 
difference between emergency and planned CS on the risk of ASD.	
Conclusion: Across the five countries, emergency or planned CS is consistently associated with a 
modest increased risk of ASD from gestational week 36 to 42 when compared to vaginal delivery. 
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Caesarean section (CS) is associated with a modest increased risk of autism when compared to 
vaginal delivery. 
Compared to vaginal delivery, CS is consistently associated with an increased risk of autism 
throughout all gestational weeks 36-42. Thus, the observed risk during this gestational period 
cannot be attributed to effects of preterm birth for children delivered by CS. 








There has been a 20-fold increase in the diagnosis of autism spectrum disorder (ASD) since the 
1980s 1–5 and it is believed that both genetic and environmental risk factors are important 
contributors 6,7. Over a similar time period there has been an increasing trend in deliveries by 
Caesarean section (CS). In some populations close to half of all births are delivered by CSs 8,9. In a 
US study, the population attributable fraction for ASD in relation to CS was estimated to be 7% for 
children born in 2000, higher than that for preterm birth and small for gestational age 10. It is 
therefore of major etiological, clinical and public health interest to examine the relation between 
ASD and CS. 
A positive association between CS and ASD has been shown in several earlier studies, but the 
results have varied in effect size 11–15. A recent meta-analysis reported that delivery by CS was 
associated with a 23% increased risk of ASD when compared to vaginal delivery 16. One possible 
explanation for the impact of CS on ASD is the fact that planned CS is normally scheduled weeks 
before the full 40-week gestation to avoid spontaneous labour 17.	It is also possible that the last few 
weeks before term are important for brain development 18. Thus deliveries before the full-term 
might increase the risk of ASD, a hypothesis which is supported by previous studies of gestational 
age risk in relation to ASD 3,4,10,19–21. Another aspect is the underlying indications leading to CS, 
which can vary by gestational ages 22. Since the underlying maternal or fetal indications leading to 
emergency CS may be important independent risk factors of ASD, the magnitude of the 
independent risks of emergency CS on ASD may also vary by gestational ages 22. We made a 
substantial search among the studies included in the most recent meta-analysis 16, and among all the 
studies cited in our study, to find any studies that investigated the association of CS and ASD 
stratified by gestational age. While many of the studies included gestational age 14,23–29 as a 
confounder, only one study reported the adjusted OR of emergency CS and planned CS among non-
preterm births, in the appendix 11.  







As maternal and clinician preferences may play a greater role in planned than in emergency CS 34, 
outcomes due to the CS procedure itself in planned CS deliveries at or near term may be less 
confounded by underlying medical indication in comparison to emergency (non-planned) CS at 
similar gestational ages. However, none of the mentioned studies had sufficient sample size to 
assess the risk of ASD among children delivered by CS compared with children born after vaginal 
delivery across gestational age, and most of them did not differentiate between emergency and 
planned CS 3,4,10,19–21. 
The aim of our study was to test the association between CS and ASD, overall and by type of CS, 
while taking gestational age into account and using the largest prospective, population based sample 
of ASD to date. We hypothesized that the relation between CS and ASD may vary between 
gestational ages and between planned and emergency CS, where CS conducted near or at full-term 
has lower risk than CS conducted at preterm, and planned CS has a lower risk than emergency CS.  
 
METHODS 
The study uses data from the International Collaboration for Autism Registry Epidemiology 
(iCARE) 35. Access to this data is managed using the ViPAR software 36 that enables the pooled 
analysis of prospectively measured multi-national population-based data relating to ASD. Ethics 
committee approval, with waiver for informed consent, was obtained by each site. 
Study population 
The study population includes all singletons surviving their first year of living in Norway and 
Sweden 1984-2004; Denmark 1997-2004; Finland 1987-2004 and the non-Aboriginal population in 
Western Australia (WA) 1984-1999. Multiple births are highly correlated with ASD risk as well as 
with both preterm birth and CS which could introduce bias 37. Excluding multiple births also 
reduces the risk of dependencies in the data which could affect the variance estimates. The final 
study sample size was not based on any statistical criteria but used all eligible national birth cohorts 







available databases for population based autism research. 
ASD outcome, CS, gestational age and covariate information	
Children were followed from birth to reported diagnosis of ASD or end of follow up which ever 
came first; through 2004 in WA, 2006 in Norway and 2009 in Denmark, Finland and Sweden. 
Denmark, Finland and Sweden provided ASD diagnoses from medical registries. ASD diagnoses 
from Norway and WA were derived from government-maintained service/benefits registries. Case 
identification, registry reporting procedures, details on the validity of case status and harmonization 
of diagnostic codes across sites have been described elsewhere 23. Paternal and maternal age, 
gestational age, sex, birth year and mode of birth delivery were obtained from birth or civil 
registries. For all countries in the study, throughout the births cohort in this study, mode of delivery 
was classified as vaginal or CS, with CS being further classified as planned, emergency, or 
unspecified. A planned CS is a planned before the onset of labour. Emergency CS is performed 
either before the onset of labour (due to medical or pregnancy complications) or complications in 
labour. Availability of data on mode of delivery and type of CS (planned, emergency, or 
unspecified) is presented in the online appendix (ST 1A). 
Primarily, gestational age was estimated using ultrasound measurement throughout the study period 
for all studied countries. More specifically, gestational age in the Nordic countries was previously 
based on the date of last menstrual period (LMP), but since 1970s ultrasound measurements have 
been increasingly used to correct LMP. In Denmark, ultrasound-based pregnancy dating was used 
to determine gestational age for 93% of those born in 1995 and 2000 38. In Sweden, since 1990, 
early second trimester ultrasound examination is routinely offered, and more than 95% of women 
accepted this offer; otherwise the date of LMP is used 24. In Finland, gestational age was estimated 
from the LMP, unless there was a discrepancy with the first-or second-trimester ultrasound 
examination of more than seven or 14 days, respectively, in which case the latter measurements 
were used 24. In Norway, gestational age is estimated by ultrasound examination since 1967, with 









The primary analyses used a two-step approach. First, as commonly used in earlier studies, we 
estimated the risk of ASD comparing births following any type of CS with birth following vaginal 
delivery, which facilitates comparisons with previous findings. The odds ratio (OR) of ASD among 
births delivered by CS compared with vaginal delivery was obtained by fitting ordinary logistic 
regression models. We first estimated the OR for ASD overall, then in gestational age subgroups: 
weeks 26-36 (preterm), weeks 37-38 (early term), weeks 39-41 (term) and weeks 42-44 (post-term), 
and finally by week of gestation except for weeks 26-30, for which data were too sparse for week-
by-week analysis. All models included sex, site, birth year (1984-89,1990-1994,1995-99, and 2000-
2004), categorized maternal age (<25,25-29,30-34,35-39,≥40) and gestational age (by week or 
subgroup) as covariates, if not otherwise specified.  
The medical indication for women undergoing either emergency or planned CS might be different. 
Thus, in the second step analysis we also estimated OR of ASD among births delivered by 
emergency CS compared with planned CS (unspecified CS were excluded from this analysis). Due 
to lack of data on CS type at some sites at different time periods (ST 1A) these analyses were 
restricted to birth cohorts 1997-2004 for Denmark, 1984-1999 for WA, 1988-2004 for Norway and 
Sweden, and 1990-2004 for Finland. For the analysis of emergency versus planned CS, we refitted 
the models adjusting for site, sex, birth year and categorized maternal age by week of gestation 
(weeks 26-30 as a single subgroup). 
Site comparisons 
Site-specific ORs of ASD among births delivered by CS compared with vaginal delivery were 
estimated by stratifying gestational age subgroup, and each week of gestation. Site heterogeneity 
and its influence on overall results were addressed by Cochran’s Q test and by verifying pooled 







site being removed. 
Subgroup and sensitivity analyses  
ORs of ASD were estimated for CS in comparison with vaginal delivery in subgroups of gestational 
age (weeks 26-36, 37-38, 39-41 and 42-44) for male and female offspring respectively. We repeated 
these analyses for Autistic Disorder (AD) cases only. Due to low frequency in some subgroups, 
analyses by week of gestation were not feasible.  
As the likelihood of CS is much higher in women who have had a CS in a previous pregnancy, we 
repeated the primary analyses restricting to first-born children only. Since information on paternal 
age was not available for Finnish births, the primary analyses did not include paternal age as a 
covariate. In a set of sensitivity analyses, having excluded Finland from the analysis dataset, we 
repeated the primary analyses by gestational age subgroups after adding paternal age (<25, 25-29, 
30-34, 35-39 and ≥40 years) to the models together with the other model terms. 
A logistic regression model assumes that all subjects have been observed for the same length of 
time (i.e., equal length of follow-up or risk time) or that the length of follow-up does not affect the 
risk. If this assumption is violated, bias may be introduced. For this purpose, birth year was 
included in all models. We also performed a sensitivity analysis on data from Denmark, Finland and 
Sweden, as these countries had information about the date of ASD diagnosis. For the sensitivity 
analyses, comparing between CS and vaginal delivery, we estimated the Hazard Ratios (HR) of 
ASD across subgroups of gestational age based on the hazard ratio obtained by fitting stratified Cox 
regression with age at diagnosis as the underlying time scale, adjusting for site, sex and maternal 
age group. To adjust for calendar effects, we fitted the Cox regression with different strata for each 
birth year group 26.  
All statistical tests were performed using the two-sided 5% level of significance and corresponding 
two-sided 95% CI's. We did not adjust for multiplicity of statistical tests. It was not possible to 
identify siblings in the data and correct for possible sibling correlations in the analyses. Models’ 







test. All statistical analyses were performed using the R-software ver3.2.1. 
 
RESULTS 
The study cohort included a total of 5 250 034 births. After sequentially excluding 99 072 who were 
born very early (<26) or very late (>44) gestational age, 146 619 multiple births and 16 957 who 
died before age of one-year, 4 987 390 (95% of the total) remained in the final data for analysis (ST 
1B). Sweden contributed 41% of the final data, Norway and Finland each contributed around 21%, 
and Denmark and WA each contributed less than 10%. Of the final data, a total 4 315 744 (86.5%) 
children were delivered by vaginal births, 243 749 (4.9%) by planned CS, 291 106 (5.9%) by 
emergency CS, and 136 791 (2.7%) by unspecified CS. There were 31 073 (0.6%) children with 
ASD of which 10 418 children were diagnosed with AD (0.2% of total). Study cohort distributions 
of births, ASD and AD cases, sex, birth year, parental age and sites are shown in Table 1 by mode 
of delivery. 	
[Table 1 here] 
The vast majority of the deliveries (96.3%) were in gestational weeks 36-42 (ST 2). The most 
frequently occurring gestational age at delivery was 40 weeks for vaginal birth (30.4%), 38 weeks 
for planned CS (34.6%), 39 weeks for emergency CS (21.2%), and 38 weeks for unspecified CS 
(24.4%). The absolute risk of ASD declined with increased gestational age: the risk of ASD 
declined from 1.42% at gestational weeks 26-30 to 0.3% at gestational weeks 44 (ST 3). Overall, 
birth deliveries by CS had a higher risk to develop ASD than vaginal births throughout gestational 
weeks 26-44.  
[Table 2 here] 
Caesarean section vs vaginal delivery by gestational ages 
The upper part of table 2 summarizes the results of the primary analysis. Compared to vaginal 







adjustment of potential confounders (site, birth year, sex and maternal age): crude OR=1.33 (95% 
CI: 1.29 - 1.37) and adjusted OR=1.32 (95% CI: 1.28-1.36). Further adjustment by including 
gestational age as a covariate resulted in OR=1.26 (95% CI: 1.22-1.30). As shown in figure 1, the 
OR of ASD following CS was statistically significantly elevated across all gestational age 
subgroups (26-36, 37-38, 39-41 and 42-44 weeks gestation). When the OR of ASD was estimated 
by week of gestation, we found a statistically significant association between CS and ASD starting 
from week 36 through week 42 (Figure 2). 
Emergency vs planned CS 
The risk of ASD was similar for emergency and planned CS, both overall (OR=0.99, 95% CI: 0.92-
1.06) and by gestational week (Figure 3). Broadly similar OR patterns were seen for ASD when 
comparing emergency CS with vaginal delivery and planned CS with vaginal delivery across 
gestational age (SF 1a, SF 1b, respectively). 
Site comparison: Caesarean section vs vaginal delivery by gestational ages 
Between sites, there were broadly similar OR patterns for ASD in children delivered by CS 
compared with children delivered by vaginal delivery by gestational age group (Figure 4 and ST 4). 
In the 37-38 weeks gestational age group, only Denmark had an OR point estimate less than 1. In 
the 39-41 weeks gestational age group, all ORs were greater than 1. Although Norway had a 
somewhat higher OR point estimate in the gestational age group 39-41 weeks, the direction was 
consistent with other sites. In the per week of gestation analysis, there was a statistically significant 
higher risk of ASD in children born by CS at 36-42 weeks gestation, which was consistent across 
sites (SF 2). The heterogeneity (Cochrane Q) test results indicated no site heterogeneity (all p-value > 
0.9). We found no quantitative differences in the estimated ORs of ASD among children delivered 
by CS compared with vaginal delivery in the site influence analysis (SF 3).  
Subgroup and sensitivity analyses 







boys (OR=1.25, 95% CI: 1.20-1.29) and girls (OR=1.30, 95% CI: 1.22-1.38). The gestational age 
group 39-41 weeks had the highest point estimate of OR for both sexes (SF 4 and ST 5). 
The results of the sensitivity analyses for ASD are given in the lower part of Table 2. Restricting to 
first-born children, the OR for ASD, CS versus vaginal delivery, was estimated to OR=1.22 (95% 
CI: 1.15-1.30). Excluding Finland and adding paternal age as a covariate, the OR for ASD, CS vs 
vaginal delivery, was OR=1.27 (95% CI: 1.22-1.31). The OR estimate only differed by the 4th 
decimal when we excluded paternal age in this restricted cohort. Using Cox regression models, the 
HR for ASD, CS vs vaginal delivery, was HR=1.27 (95% CI: 1.23–1.31). Restricted to the same 
date-of-diagnosis cohort (Denmark, Finland and Sweden), the OR for ASD, CS versus vaginal 
delivery, was OR=1.25 (95% CI: 1.21-1.29). 
The results of AD are summarized in ST 6-7. Without adjustment for gestational age, the OR for 
AD from CS compared with vaginal delivery was 1.42 (95% CI: 1.35-1.49) and after including 
gestational age (26-36, 37-38, 39-41 and 42-44 weeks) the OR was estimated to 1.34 (95% CI: 
1.27-1.41). The results of all the sensitivity analyses (first-born only, including paternal age 
[Finland excluded], and Cox regression analysis) were similar and the estimated ORs and HRs 
ranged from 1.31-1.35. CS was significantly associated with AD in all gestational age subgroups 
(26-36, 37-38, 39-41 and 42-44 weeks) (SF 5).  
For all analyses (ASD, AD and subgroups), the goodness-of-fit analyses (Hosmer-Lemshow test), 
supported the assumption of data following a binomial distribution.  
 
DISCUSSION	
To date, this is the largest population-based study of association between Caesarean section and the 
risk of ASD. We included five million singletons in five countries (Norway, Sweden, Denmark, 
Finland and Western Australia) with more than 31 000 prospectively ascertained cases of ASD. 







delivery, consistently from 36 weeks to 42 weeks of gestation. On average, a 26% higher risk of 
ASD was presented in all births from week 36 to 42 representing 95% of the total number of births 
or 90% of all CS births. There was no evidence for differences in ASD risk between emergency CS 
and planned CS, overall or by week of gestation. Similar overall risk patterns were observed for 
males and females and for AD specifically, and the patterns remained robust across a variety of 
sensitivity analyses. 
Different from previous studies 11–16,27,28,39–42, and made possible by the high statistical power, we 
were able to precisely estimate the association between CS and ASD in specific weeks of gestation, 
in subgroups of male and female offspring and for AD separately. Using a long study period, 
including sites with different type of diagnostic registries (medical registries vs government-
maintained service/benefits registries), varying incidence of CS and ASD and different medical 
practice (planned CS without medical indication is more common in WA than Nordic counties) 
strengthens the generalizability of our results. 
Our results did not support our original hypotheses that CS conducted at or near full-term has lower 
risk than CS conducted at preterm, or that emergency CS has a higher risk of ASD than planned CS. 
Although the precision of the risk estimates is lower for below 36 weeks of gestation compared to 
36-42 weeks, the point estimates for ASD risk from CS below 36 weeks did not indicate any 
increased risk. This could mean that CS alone before 36 weeks does not add any additional risk for 
ASD, beyond the risks associated with the adverse medical indications leading to CS or with fetal 
prematurity. In contrast, CS may confer additional risk for ASD above risks associated with factors 
leading to CS between 36-42 weeks gestation. Also, since the risks from planned and emergency 
CS were very similar, even during weeks 36-42 gestation, it indicating there might by induced risk 
from CS per se at or near term.  A previous meta-analysis was carried out to examine the 
association between CS and ASD 16. When restricted to the 13 studies which had adjusted for other 
covariates (only nine of which were published after 1990 12–15,27,28,39–41 and only one of which 39 had 







pooled estimate is similar in magnitude to our overall estimate but with considerably lower 
precision.  
In addition to the “before term” hypothesis, there are several other hypotheses regarding the 
potential relationship between delivery by CS and ASD. In one study of first born children, the risk 
of ASD was 52% higher in infants whose CS was performed under general anaesthesia than those 
who were delivered vaginally or born through CS under regional anaesthesia 42. Neurotoxicity 
related to neonatal exposure to general anaesthesia might be a contributing factor. However, we 
found that the OR for ASD following emergency CS (more likely to be performed under general 
anaesthesia) was similar to the OR following planned CS. Exposure to skin microbiota due to the 
CS procedure 29 and the beneficial effect of being born vaginally (enhance the immune system) 43–45 
are other potential hypotheses. Lastly, there are indications that CS may increase risk of 
immunological diseases since the child is not exposed to the stress following a vaginal delivery 46.                      
which normally would initiate positive changes in epigenetic expression. 
Even though CS, planned or emergency, appears to be associated with of a complex mix of factors 
also associated with ASD risk 47, we did not see a difference in risk of ASD from planned versus 
emergency CS, even in near term and term deliveries. Similar to our results, a recent population-
based study 11 reported that both elective (planned) CS and emergency CS were associated with 
increased risk of ASD also when adjusting for selected confounding factors. By restricting the 
population to families with at least two siblings they were able to further adjust for familial 
confounding. When adjusting for familial confounding neither emergency CS nor elective CS was 
associated with ASD, indicating the association may not be directly causal and implying that 
unknown familial factors might explain the increased risk of both CS and ASD. However, bias from 
residual confounding may still remain, e.g., confounding by calendar time arising from changes in 
obstetric practice over time. In addition, mode of delivery in one pregnancy influences mode of 
delivery in a subsequent pregnancy, which cannot be controlled for in a sibling design. Assuming 







potential biases, our results indicate that the ORs associated with these familiar factors increase the 
risk of CS and ASD consistently, across gestational week 36 to 42. A similar pattern also appeared 
consistently across study sites. Further work is needed to disentangle the contributions to ASD risk 
arising from the underlying indications versus the procedure itself, also in planned CS. 
The major strength of this study is the large multi-national sample size with prospective follow-up. 
With approximately 5 million live born singletons and 31 073 ASD cases, our study is more than 
three times larger than the previous meta-analyses 16,48 and almost twice the size of the recent 
Swedish study, thus providing higher statistical power to conduct more detailed subgroup analyses. 
For instance, in the gestational week-by-week analyses conducted by each site alone (SF 2), all 95% 
CIs included 1.0 (with only exception at gestational week 44 for Norway) despite the consistent 
elevated ORs from gestational week 36-44 across sites. Our study also has limitations: the follow-
up period from birth to reported diagnosis of ASD is too short for some of the birth years. For 
example, in Norway the follow-up was until 2006, but the last birth year included was 2004, i.e., the 
age of the child was two years old and unlikely to be diagnosed with ASD.  Since logistic 
regression is not able to directly adjust for the differences in length of follow-up for different 
individuals due to censoring, a bias may have been introduced. For this reason we fitted Cox 
regression as a complementary model. Even though we did not have information for all types of 
censoring, e.g. date of emigration or date of death of a child, it should not effect the results. First, 
we only included children surviving their first year of life, removing the possibility of early 
censoring due to infant death, although the child death rates in the countries in the study are among 
the lowest in the world. Second, emigration out of the Nordic countries is very low. Third, bias 
could be introduced if participants are lost to follow-up due to reasons related to CS or gestational 
age. We see no reason to suspect differences in follow-up due to CS, although children born early 
or late term gestational age could be at slightly higher risk of censoring due to death or co-
morbidity hiding symptoms of autism. Nevertheless, the ORs from logistic regression agreed very 







frequency between countries. For example, the prevalence of ASD is about one fifth in Norway 
compared to the other countries. One possible explanation is the diagnostic data from Norway were 
derived from government-maintained service/benefits registries, while other countries’ diagnostic 
data were from medical registries (with WA as an exception). Results from the leave-one-out site 
influence analysis indicated that the different type of diagnostic data did not influence the estimated 
ORs. Our study also has similar limitations as previous studies in that we did not have access to the 
underlying indication for CS or the sufficient information to conduct sibling designed analysis. 
While several potential confounders, e.g., parental psychiatric information, maternal diabetes, pre-
eclampsia and socioeconomic status are available in each site, iCARE data does not contain such 
information. Also, iCARE was purposely designed to focus only on ASD and does not contain 
information on other psychological developments, such as ADHD and intellectual disability, which 
have also been reported to be associated with CS as well 15,49,50. As ultrasound dating of pregnancies 
was not universally used throughout the cohort, there may be some (but not) large inaccuracy in 
gestational age. However, the distribution of gestations periods at delivery (with the vast majority 
delivered at term) is reassuring in this regard. Due to the constraint of information available in the 
database, our classification of CS (planned and emergency) might be too simple. WHO 
recommended the 10-group classification (also known as Robson’s classification) as a global 
standard for assessing, monitoring and comparing CS rates internationally based on simple obstetric 
parameters (parity, previous CS, gestational age, onset of labor, fetal presentation and number of 
fetuses). However, this classification still does not explicitly record the underlying indication for 
doing CS nor differentiation of elective (maternal request in the absence of maternal or fetal 
indications) and emergency CS. Finally, we could not take into account the date of death and the 
date of immigration in the Cox regression analysis since iCARE does not contain such information. 
CONCLUSION 
Across the five countries, birth delivery by CS, planned or emergency, is consistently associated 







delivery. These findings may have important implications, especially given the rise in CS around 
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